Table 2. Response rate according to pre-treatment LDH levels in the bevacizumab group and in the control group.

	Control group			Bevacizumab group
	LDH <588	LDH >588	P-value	LDH <558	LDH >588	P-value
Partial+complete response	46 (39%)	4 (20%)	0.1671	8 (14%)	14 (58%)	0.0243
Stable disease	46 (39%)	2 (10%)	0.0237	40 (69%)	8 (36%)	0.0063
Progressive disease	26 (22%)	14 (70%)	<0.0001	10 (17%)	2 (8%)	0.48
	118	20		58	24
	138			82

Abbreviation: LDH=lactate dehydrogenase.